Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

But these drugs might also protect brain health, researchers found. SGLT2 inhibitors are associated with a 20% reduced risk ...

Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Increased exposure to air pollution in the form of particulate matter with a diameter of 2.5 µm or less (PM2.5) and nitrogen ...

It could be a medical condition called essential tremor, and a new study by Singapore’s National Neuroscience Institute has ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...